Global tryptophan market is expected to register a healthy CAGR of 13.9% in the forecast period of 2019-2026. Rising consumption of health products and dietary supplements is the major factor for the growth of the market. The report contains data from the historic year of 2017, base year of 2018.
Key Developments in the Market:
- In June 2016, Evonik Industries AG had introduced L-valine to its amino acid portfolio for animal nutrition making the swine and poultry feed quite efficient. L-valine plays an important role as it is required for protein biosynthesis. It also minimizes the feed cost and assist in conserving the natural resources in agricultural feed production preventing gas emission, eutrophication among others. With this launch the company expands its product portfolio in the market
- In November 2014, AJINOMOTO CO.INC increases production capacity of tryptophan from 4,500 tons to 7,500 tons in France. This will improve its effectiveness and strengthening the flexibility of production
Competitive Analysis:
Global tryptophan market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of tryptophan for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Key Market Competitors:
Few of the major competitors currently working in global tryptophan market are AMINO GmbH, Avantor, Inc., MEIHUA HOLDINGS GROUP CO., LTD, Parchem fine & specialty chemicals, Swanson, AJINOMOTO CO.,INC ., Cargill, Incorporated, CJ CHEILJEDANG CORP., KYOWA HAKKO BIO CO.LTD., Penta Manufacturer, DAESANG Corporation, Archer Daniels Midland Company, Evonik Industries AG, NOVUS INTERNATIONAL, Glanbia plc, Unisplendour (Europe) Amino Acids B.V., Bluestar Adisseo Co., Ltd., Sumitomo Chemical Co., Ltd., The Good Scents Company (tgsc), Merck KGaA among others.
No comments:
Post a Comment